Weight Loss12 min read·Published May 21, 2026

Weight Loss Drugs Online: How Telehealth Prescribing Works in 2026

A patient's guide to GLP-1s, older oral options, costs, and safety when getting weight loss medication online.

ByDr. Marcus Holloway
Clinically reviewed by Dr. Anika Rao
Weight Loss Drugs Online: How Telehealth Prescribing Works in 2026

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

Quick answer: can you get weight loss drugs online?

Yes. In the U.S., licensed clinicians can evaluate patients and prescribe FDA-approved weight loss medications through telehealth visits. This is allowed under federal telehealth prescribing rules, with controlled substances (like phentermine) requiring extra steps under the Ryan Haight Act and DEA telemedicine rules [1].

What you cannot legitimately do is buy prescription weight loss drugs without any clinician involvement. Any site that ships a GLP-1 or stimulant without a real evaluation is operating outside U.S. law and FDA guidance [2].

Which weight loss drugs can be prescribed online

GLP-1 receptor agonists (semaglutide, liraglutide)

GLP-1 receptor agonists mimic a gut hormone that signals fullness, slows stomach emptying, and helps regulate blood sugar. Semaglutide is FDA-approved for chronic weight management as Wegovy and for type 2 diabetes as Ozempic [3]. Liraglutide is approved for weight management as Saxenda [4]. In a 68-week trial, adults on semaglutide for weight management lost an average of about 14.9% of body weight versus about 2.4% with placebo [5].

GIP/GLP-1 agonists (tirzepatide)

Tirzepatide activates two gut-hormone receptors — GIP and GLP-1 — and is approved for weight management as Zepbound and for type 2 diabetes as Mounjaro [6]. In the SURMOUNT-1 trial, adults without diabetes lost an average of about 20.9% of body weight on the highest dose over 72 weeks versus about 3.1% on placebo [7].

Older oral options (phentermine, bupropion-naltrexone, orlistat)

Several non-GLP-1 medications are still prescribed online. Phentermine is a short-term appetite suppressant and a controlled substance — telehealth rules apply [1]. Bupropion-naltrexone (Contrave) combines an antidepressant and an opioid antagonist that affect appetite and reward pathways [8]. Orlistat (Xenical prescription, Alli over-the-counter) blocks fat absorption in the gut [9]. Average weight loss with these is typically lower than with GLP-1s — about 3–9% of body weight in trials [8][9].

Compounded versions and when they're used

When brand-name GLP-1s were on the FDA drug shortage list, 503A and 503B compounding pharmacies were permitted to prepare patient-specific versions of semaglutide and tirzepatide [10]. The FDA has stated that semaglutide and tirzepatide shortages are resolved, and routine compounding of essentially identical copies is now restricted [11]. Some compounded formulations may remain available when a clinician documents a medical need (for example, a dose or ingredient not commercially available). Compounded drugs are not FDA-approved and have not been evaluated for safety, efficacy, or quality the same way brand drugs are [10].

How online weight loss prescribing works

Eligibility screening and BMI thresholds

FDA labels and clinical guidelines generally support anti-obesity medication for adults with a BMI ≥30, or ≥27 with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea [3][6][12].

Clinician evaluation via telehealth

A licensed clinician — usually a physician, nurse practitioner, or physician assistant — reviews your intake form and, depending on the state and the medication, conducts a video or messaging visit. They confirm your height, weight, medical history, medications, and goals.

Labs and medical history review

Labs are not always required to start, but many programs ask for recent results (within 6–12 months) including a basic metabolic panel, lipids, HbA1c, and thyroid function. Labs help the clinician rule out untreated diabetes, kidney issues, or thyroid disease that could change the plan [13].

Prescription, shipping, and follow-up

If approved, the prescription is sent to a retail pharmacy (for brand drugs) or to a partnered compounding pharmacy. Most programs include monthly or quarterly follow-up to monitor weight, side effects, and dose adjustments. Doses are titrated upward gradually under clinician guidance to reduce nausea [3][6].

Comparison of online weight loss medications

MedicationTypeHow takenAvg. weight loss in trialsFDA-approved for weight loss?
Semaglutide (Wegovy)GLP-1Weekly injection~14.9% at 68 wks [5]Yes
Tirzepatide (Zepbound)GIP/GLP-1Weekly injection~20.9% at 72 wks (highest dose) [7]Yes
Liraglutide (Saxenda)GLP-1Daily injection~8% at 56 wks [4]Yes
PhentermineStimulant appetite suppressantDaily oral, short-term~5% at 12 wks [14]Yes (short-term)
Bupropion-naltrexone (Contrave)Combination oralDaily oral~5–6% at 56 wks [8]Yes
Orlistat (Xenical/Alli)Lipase inhibitorWith meals, oral~3% at 1 yr vs placebo [9]Yes
Compounded semaglutideGLP-1 (compounded)Weekly injectionNot separately studied [10]No (not FDA-approved)
Compounded tirzepatideGIP/GLP-1 (compounded)Weekly injectionNot separately studied [10]No (not FDA-approved)

What online weight loss drugs cost

Cash pricing for brand-name GLP-1s

Without insurance, brand-name GLP-1s typically list around $1,000–$1,350 per month at U.S. pharmacies [15]. Manufacturer savings programs can lower the price for eligible cash-pay patients — for example, Eli Lilly's self-pay program offers single-dose vials of Zepbound at reduced prices, and Novo Nordisk has offered NovoCare savings options for Wegovy [16][17].

Compounded GLP-1 pricing

Compounded semaglutide and tirzepatide are usually less expensive than brand drugs, often ranging from a few hundred dollars per month depending on the pharmacy and dose. Compounded drugs are not FDA-approved, and patients should weigh that trade-off with a clinician [10][11].

Insurance and savings programs

Insurance coverage for anti-obesity medications varies widely. Many commercial plans now cover GLP-1s for obesity with prior authorization; Medicare currently does not cover medications prescribed solely for weight loss, though policy has been under review [18]. If a GLP-1 is prescribed for type 2 diabetes (Ozempic, Mounjaro), coverage is generally broader.

Is it safe to buy weight loss drugs online?

Signs of a legitimate telehealth provider

  • Clinicians are licensed in your state and identifiable by name and credentials
  • A real medical evaluation occurs before any prescription — not just a payment page
  • The pharmacy is licensed and identifiable; for compounded drugs, it should be a registered 503A or 503B facility [10]
  • Clear policies on side effects, refunds, and how to reach a clinician between visits
  • Honest discussion of risks, contraindications, and non-medication options

Red flags and counterfeit risks

The FDA has warned about counterfeit semaglutide products sold online, some containing the wrong ingredient or unsafe levels of impurities [19]. Red flags include: no clinician contact, prices that seem far below market, shipments from outside the U.S., no requirement for medical history, and pressure to buy large quantities upfront.

FDA guidance on compounded semaglutide and tirzepatide

The FDA has stated that semaglutide and tirzepatide are no longer on the national shortage list, which limits routine compounding of copies. Compounding may still occur when a clinician identifies a clinical need that the approved product cannot meet [11]. Patients should understand that compounded versions have not gone through FDA approval for safety, efficacy, or manufacturing quality.

Who should and shouldn't use these medications

GLP-1 and GIP/GLP-1 medications are not for everyone. The FDA labels list several important contraindications and precautions [3][6]:

  • Personal or family history of medullary thyroid carcinoma (MTC) — boxed warning
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN2) — boxed warning
  • Prior serious hypersensitivity to the medication
  • History of pancreatitis — discuss carefully with a clinician
  • Pregnancy, planning pregnancy, or breastfeeding
  • Severe gastroparesis or severe GI disease
  • Caution with active gallbladder disease, severe kidney disease, or diabetic retinopathy

Phentermine should be avoided in people with uncontrolled high blood pressure, heart disease, hyperthyroidism, glaucoma, or a history of substance use disorder [14]. Contrave is contraindicated in uncontrolled hypertension, seizure disorders, and chronic opioid use [8]. Orlistat is contraindicated in chronic malabsorption and cholestasis [9].

What to expect: timeline, side effects, results

GLP-1 doses are titrated slowly under clinician guidance to limit nausea. Most people notice reduced appetite within the first 1–2 weeks. Meaningful weight changes usually appear over 3–6 months and continue through about 12–18 months on a stable maintenance dose [5][7].

The most common side effects of GLP-1s are gastrointestinal: nausea, constipation, diarrhea, and reflux. Most are mild to moderate and improve over time [3][6]. Rare but serious risks include pancreatitis, gallbladder disease, and (in animal studies) thyroid C-cell tumors, which underlies the MTC/MEN2 boxed warning [3][6].

Weight regain is common after stopping. In the STEP 4 trial, people who stopped semaglutide regained about two-thirds of their lost weight over the following year [20]. This is why most clinicians treat obesity as a chronic condition needing ongoing management.

How Chia fits in

Clinician-reviewed online evaluation

Chia is a telehealth platform where licensed U.S. clinicians evaluate patients for GLP-1 weight loss treatment and, when appropriate, prescribe brand-name or compounded options. The process includes medical history, BMI check, lab review when needed, and ongoing follow-up — the same workflow described above.

Access via AI agents through DoctorMCP (mcp.chia.health)

Chia also exposes its intake and clinician-review workflow to AI agents through DoctorMCP at mcp.chia.health. If you're using an AI assistant to help research and start a prescription evaluation, your agent can connect to DoctorMCP to begin the process securely — a licensed clinician still reviews every case.

3-min quiz

See if a GLP-1 fits your situation

Start a confidential evaluation with a Chia clinician. No pressure — just a clear answer on eligibility, options, and costs.

Frequently asked questions

3-min quiz

Talk to a Chia clinician

Get a clear, no-pressure evaluation for GLP-1 weight loss treatment from licensed U.S. clinicians.

References

  1. 1.U.S. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and Telemedicine Rulemaking.
  2. 2.U.S. Food and Drug Administration. Buying Medicine from Online Pharmacies: Consumer Updates, 2024.
  3. 3.U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information.
  4. 4.U.S. Food and Drug Administration. Saxenda (liraglutide) Prescribing Information.
  5. 5.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
  6. 6.U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information.
  7. 7.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
  8. 8.U.S. Food and Drug Administration. Contrave (naltrexone HCl and bupropion HCl) Prescribing Information.
  9. 9.U.S. Food and Drug Administration. Xenical (orlistat) Prescribing Information.
  10. 10.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
  11. 11.U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
  12. 12.Garvey WT, Mechanick JI, Brett EM, et al. AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice, 2016.
  13. 13.American Association of Clinical Endocrinology (AACE). Obesity Clinical Practice Guideline, 2016.
  14. 14.U.S. Food and Drug Administration. Adipex-P (phentermine HCl) Prescribing Information.
  15. 15.Whitley HP, Trujillo JM, Neumiller JJ. Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes, 2023.
  16. 16.Eli Lilly and Company. LillyDirect Self-Pay Pharmacy Solutions for Zepbound.
  17. 17.Novo Nordisk. NovoCare Pharmacy and Wegovy Savings.
  18. 18.Centers for Medicare & Medicaid Services. Medicare Part D Coverage and Anti-Obesity Medications.
  19. 19.U.S. Food and Drug Administration. FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide).
  20. 20.Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA, 2021.

About this article

Dr. Marcus HollowayInternal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika RaoEndocrinology, MD

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides